Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent.

about

Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas.SOX11 promotes invasive growth and ductal carcinoma in situ progression.

P2860

Q36544839-DEF4AD6A-5C7E-42EA-9405-CC3540A1C2E0 Q42512378-75BDDC1A-DA66-464E-A714-1128A8B1543A

P2860

Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent.

Item

http://www.wikidata.org/entity/Q48158656

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Stem cell biomarker ALDH1A1 in ...... t is highly cut-off dependent.

@en

Stem cell biomarker ALDH1A1 in ...... t is highly cut-off dependent.

@nl

type

Item

label

Stem cell biomarker ALDH1A1 in ...... t is highly cut-off dependent.

@en

Stem cell biomarker ALDH1A1 in ...... t is highly cut-off dependent.

@nl

prefLabel

Stem cell biomarker ALDH1A1 in ...... t is highly cut-off dependent.

@en

Stem cell biomarker ALDH1A1 in ...... t is highly cut-off dependent.

@nl

P1476

Stem cell biomarker ALDH1A1 in ...... t is highly cut-off dependent.

@en

P2093

Cecilia Hegardt

http://www.w3.org/2001/XMLSchema#string

Dorthe Grabau

http://www.w3.org/2001/XMLSchema#string

Emma Niméus

http://www.w3.org/2001/XMLSchema#string

Gabriella Honeth

http://www.w3.org/2001/XMLSchema#string

Linda Hartman

http://www.w3.org/2001/XMLSchema#string

Martin Sjöström

http://www.w3.org/2001/XMLSchema#string

Mårten Fernö

http://www.w3.org/2001/XMLSchema#string

P2860

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Stem cells, cancer, and cancer stem cells

Cancer stem cells: mirage or reality?

Aldehyde dehydrogenase1 immunohistochemical staining in primary breast cancer cells independently predicted overall survival but did not correlate with the presence of circulating or disseminated tumors cells

ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis

In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis.

P304

1012-1019

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JCLINPATH-2015-203092

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Per-Uno Malmström

P577

2015-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26175266

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent.

about

P2860

P2860

Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921